← Product Code [IWI](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IWI) · K882449

# CESIUM 137 SOURCE, MODEL CSM-40 (K882449)

_Cis-Us, Inc. · IWI · Apr 14, 1989 · Radiology · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IWI/K882449

## Device Facts

- **Applicant:** Cis-Us, Inc.
- **Product Code:** [IWI](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IWI.md)
- **Decision Date:** Apr 14, 1989
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 892.5730
- **Device Class:** Class 2
- **Review Panel:** Radiology

## Regulatory Identification

A radionuclide brachytherapy source is a device that consists of a radionuclide which may be enclosed in a sealed container made of gold, titanium, stainless steel, or platinum and intended for medical purposes to be placed onto a body surface or into a body cavity or tissue as a source of nuclear radiation for therapy.

## Special Controls

*Classification.* Class II (special controls). A prostate seeding kit intended for use with a radionuclide brachytherapy source only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

---

**Source:** [https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IWI/K882449](https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IWI/K882449)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com